Fibromatosis Clinical Trials

Find Fibromatosis Clinical Trials Near You

Skin Involvement in Dupuytren Surgical Treatment Outcome: Interventional Study on Prognostic Value of Cutometry, Ultrasound and Histopathology

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Palmar skin is often retracted in Dupuytren disease (DD), making surgical management challenging and skin-preserving surgery difficult. Based on clinical experience in DD surgery and outcome, it is suspected that recurrence may be associated with such retracted skin. Possibly, this is due to presence and persistence of aligned myofibroblasts (MF), fixed to the deepest dermal layers. This interventional study aims to investigate the pathophysiological involvement of palmar skin in Dupuytren disease, and its implications for prognostics and treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures.

• Patients ≥ 18 years old, diagnosed with primary Dupuytren disease.

• Patients must be scheduled for microfasciectomy.

Locations
Other Locations
Belgium
Universitaire Ziekenhuizen KU Leuven
RECRUITING
Leuven
Contact Information
Primary
Ilse Degreef, Prof. Dr.
ilse.degreef@uzleuven.be
+32 16 33 88 43
Backup
Anna Tarasiuk
orthopedie.research@uzleuven.be
+32 16 33 88 18
Time Frame
Start Date: 2024-12-10
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 50
Treatments
Other: Patients with Dupuytren disease
50 patients scheduled for microfasciectomy will be enrolled.
Related Therapeutic Areas
Sponsors
Leads: Universitaire Ziekenhuizen KU Leuven

This content was sourced from clinicaltrials.gov